<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Amikacin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Amikacin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Amikacin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Amikacin</b> is an antibiotic used for a number of bacterial infections.<span class="mw-ref" id="cite_ref-AHFS2016_4-0"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> This includes joint infections, intra-abdominal infections, meningitis, pneumonia, sepsis, and urinary tract infections.<span class="mw-ref" id="cite_ref-AHFS2016_4-1"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is also used for the treatment of multidrug-resistant tuberculosis.<span class="mw-ref" id="cite_ref-WHO2008_5-0"><a href="#cite_note-WHO2008-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is used by injection into a vein using an IV or into a muscle.<span class="mw-ref" id="cite_ref-AHFS2016_4-2"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<p></p>
<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Amikacin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Amikacin.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Amikacin.svg.png" data-file-width="1570" data-file-height="1790" data-file-type="drawing" height="251" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Amikacin_ball-and-stick.png" tppabs="https://ptable.com/wiki/compounds/I/m/Amikacin_ball-and-stick.png" data-file-width="2000" data-file-height="1418" data-file-type="bitmap" height="156" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Amikin, Amiglyde-V, Arikayce, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/amikacin-sulfate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/amikacin-sulfate.html'" tppabs="https://www.drugs.com/monograph/amikacin-sulfate.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a682661.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a682661.html'" tppabs="https://medlineplus.gov/druginfo/meds/a682661.html" class="external text external">a682661</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Amikacin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Amikacin'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Amikacin" class="external text external">Amikacin</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>D<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>D (Evidence of risk)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>intramuscular, intravenous</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Aminoglycoside</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>D06AX12<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=D06AX12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=D06AX12'" tppabs="https://www.whocc.no/atc_ddd_index/?code=D06AX12" class="external text external">WHO</a></span>)<span> </span>J01GB06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J01GB06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J01GB06'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J01GB06" class="external text external">WHO</a></span>), S01AA21<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=S01AA21  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=S01AA21'" tppabs="https://www.whocc.no/atc_ddd_index/?code=S01AA21" class="external text external">WHO</a></span>), J01RA06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J01RA06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J01RA06'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J01RA06" class="external text external">WHO</a></span>), QD06AX12<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atcvet/atcvet_index/?code=QD06AX12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atcvet/atcvet_index/?code=QD06AX12'" tppabs="https://www.whocc.no/atcvet/atcvet_index/?code=QD06AX12" class="external text external">WHO</a></span>), QJ01GB06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atcvet/atcvet_index/?code=QJ01GB06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atcvet/atcvet_index/?code=QJ01GB06'" tppabs="https://www.whocc.no/atcvet/atcvet_index/?code=QJ01GB06" class="external text external">WHO</a></span>), QS01AA21<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atcvet/atcvet_index/?code=QS01AA21  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atcvet/atcvet_index/?code=QS01AA21'" tppabs="https://www.whocc.no/atcvet/atcvet_index/?code=QS01AA21" class="external text external">WHO</a></span>), QJ01RA06<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atcvet/atcvet_index/?code=QJ01RA06  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atcvet/atcvet_index/?code=QJ01RA06'" tppabs="https://www.whocc.no/atcvet/atcvet_index/?code=QJ01RA06" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span><span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>&gt;90%<span class="mw-ref" id="cite_ref-plumb_3-0"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>0–11%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Mostly unmetabolized</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>2–3 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>kidney</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(2<i>S</i>)-4-Amino-<i>N</i>-[(2<i>S</i>,3<i>S</i>,4<i>R</i>,5<i>S</i>)-5-amino-2-[(2<i>S</i>,3<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>R</i>)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-6-(aminomethyl)-3,4,5-trihydroxy-oxan-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxybutanamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=37517-28-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=37517-28-5'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=37517-28-5" class="external text external">37517-28-5</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/37768  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/37768'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/37768" class="external text external">37768</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00479'" tppabs="https://www.drugbank.ca/drugs/DB00479" class="external text external">DB00479</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.34635.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.34635.html'" tppabs="http://www.chemspider.com/Chemical-Structure.34635.html" class="external text external">34635</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=84319SGC3C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=84319SGC3C'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=84319SGC3C" class="external text external">84319SGC3C</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D02543  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D02543'" tppabs="https://www.kegg.jp/entry/D02543" class="external text external">D02543</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:2637  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:2637'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:2637" class="external text external">CHEBI:2637</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL177  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL177'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL177" class="external text external">ChEMBL177</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3022586  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3022586'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3022586" class="external text external">DTXSID3022586</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.048.653  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.048.653'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.048.653" class="external text external">100.048.653</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>22</sub><span>H</span><sub>43</sub><span>N</span><sub>5</sub><span>O</span><sub>13</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">585.608</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28N%5BC%40H%5D3%5BC%40H%5D%28O%5BC%40H%5D1O%5BC%40%40H%5D%28%5BC%40%40H%5D%28O%29%5BC%40H%5D%28N%29%5BC%40H%5D1O%29CO%29%5BC%40%40H%5D%28O%29%5BC%40H%5D%28O%5BC%40H%5D2O%5BC%40H%5D%28CN%29%5BC%40%40H%5D%28O%29%5BC%40H%5D%28O%29%5BC%40H%5D2O%29%5BC%40%40H%5D%28N%29C3%29%5BC%40%40H%5D%28O%29CCN  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28N%5BC%40H%5D3%5BC%40H%5D%28O%5BC%40H%5D1O%5BC%40%40H%5D%28%5BC%40%40H%5D%28O%29%5BC%40H%5D%28N%29%5BC%40H%5D1O%29CO%29%5BC%40%40H%5D%28O%29%5BC%40H%5D%28O%5BC%40H%5D2O%5BC%40H%5D%28CN%29%5BC%40%40H%5D%28O%29%5BC%40H%5D%28O%29%5BC%40H%5D2O%29%5BC%40%40H%5D%28N%29C3%29%5BC%40%40H%5D%28O%29CCN'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28N%5BC%40H%5D3%5BC%40H%5D%28O%5BC%40H%5D1O%5BC%40%40H%5D%28%5BC%40%40H%5D%28O%29%5BC%40H%5D%28N%29%5BC%40H%5D1O%29CO%29%5BC%40%40H%5D%28O%29%5BC%40H%5D%28O%5BC%40H%5D2O%5BC%40H%5D%28CN%29%5BC%40%40H%5D%28O%29%5BC%40H%5D%28O%29%5BC%40H%5D2O%29%5BC%40%40H%5D%28N%29C3%29%5BC%40%40H%5D%28O%29CCN" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(N[C@H]3[C@H](O[C@H]1O[C@@H]([C@@H](O)[C@H](N)[C@H]1O)CO)[C@@H](O)[C@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](N)C3)[C@@H](O)CCN</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:LKCWBDHBTVXHDL-RMDFUYIESA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464364466&page2=Amikacin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464364466&page2=Amikacin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464364466&page2=Amikacin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Amikacin, like other aminoglycoside antibiotics, can cause hearing loss, balance problems, and kidney problems.<span class="mw-ref" id="cite_ref-AHFS2016_4-3"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Other side effects include paralysis, resulting in the inability to breathe.<span class="mw-ref" id="cite_ref-AHFS2016_4-4"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> If used during pregnancy it may cause permanent deafness in the baby.<span class="mw-ref" id="cite_ref-AHFS2016_4-5"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-2"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Amikacin works by blocking the function of the bacteria's 30S ribosomal subunit, making it unable to produce proteins.<span class="mw-ref" id="cite_ref-AHFS2016_4-6"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<p>Amikacin was patented in 1971, and came into commercial use in 1976.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> It is on the World Health Organization's List of Essential Medicines.<span class="mw-ref" id="cite_ref-WHO21st_8-0"><a href="#cite_note-WHO21st-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It is derived from <a href="Kanamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Kanamycin" title="Kanamycin" class="mw-redirect">kanamycin</a>.<span class="mw-ref" id="cite_ref-AHFS2016_4-7"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Amikacin is most often used for treating severe infections with multidrug-resistant, aerobic Gram-negative bacteria, especially <i>Pseudomonas</i>, <i>Acinetobacter</i>, <i>Enterobacter</i>, <i>E. coli</i>, <i>Proteus</i>, <i>Klebsiella</i>, and <i>Serratia</i>.<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-0"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> The only Gram-positive bacteria that amikacin strongly affects are <i>Staphylococcus</i><span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-1"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> and <i>Nocardia</i>.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Amikacin can also be used to treat non-tubercular mycobacterial infections and tuberculosis (if caused by sensitive strains) when first-line drugs fail to control the infection.<span class="mw-ref" id="cite_ref-AHFS2016_4-8"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is rarely used alone.<span class="mw-ref" id="cite_ref-cunha_11-0"><a href="#cite_note-cunha-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>It is often used in the following situations:<span class="mw-ref" id="cite_ref-AHFS2016_4-9"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>
<ul><li>Bronchiectasis<span class="mw-ref" id="cite_ref-medscape_12-0"><a href="#cite_note-medscape-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></li>
<li>Bone and joint infections</li>
<li>Granulocytopenia, when combined with <a href="Ticarcillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ticarcillin" title="Ticarcillin">ticarcillin</a>, in people with cancer<span class="mw-ref" id="cite_ref-aronson_13-0"><a href="#cite_note-aronson-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>Intra-abdominal infections (such as peritonitis) as an adjunct to other medicines, like <a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">clindamycin</a>, <a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">metronidazole</a>, <a href="Piperacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperacillin" title="Piperacillin">piperacillin</a>/<a href="Tazobactam.htm" tppabs="https://ptable.com/wiki/compounds/A/Tazobactam" title="Tazobactam">tazobactam</a>, or <a href="Ampicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ampicillin" title="Ampicillin">ampicillin</a>/sulbactam</li>
<li>Meningitis:
<ul><li>for meningitis by <i>E. coli</i>, as an adjunct to <a href="Imipenem.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipenem" title="Imipenem">imipenem</a></li>
<li>for meningitis caused by <i>Pseudomonas</i>, as an adjunct to <a href="Meropenem.htm" tppabs="https://ptable.com/wiki/compounds/A/Meropenem" title="Meropenem">meropenem</a></li>
<li>for meningitis caused by <i>Acetobacter</i>, as an adjunct to imipenem or <a href="Colistin.htm" tppabs="https://ptable.com/wiki/compounds/A/Colistin" title="Colistin">colistin</a></li>
<li>for neonatal meningitis caused by <i>Streptococcus agalactiae</i> or <i>Listeria monocytogenes</i>, as an adjunct to ampicillin</li>
<li>for neonatal meningitis caused by Gram negative bacteria such as <i>E. coli</i>, as adjunct to a 3rd-generation cephalosporin</li></ul></li>
<li>Mycobacterial infections, including as a second-line agent for active tuberculosis.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> It is also used for infections by <i>Mycobacterium avium</i>, <i>M. abcessus</i>, <i>M. chelonae</i>, and <i>M. fortuitum</i>.</li>
<li><i>Rhodococcus equi</i>, which causes an infection resembling tuberculosis</li>
<li>Respiratory tract infections, including as an adjunct to beta-lactams or carbapenem for hospital-acquired pneumonia</li>
<li>Sepsis, including that in neonates,<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-2"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> as an adjunct to beta-lactams or carbapenem</li>
<li>Skin and suture-site infections<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-3"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></li>
<li>Urinary tract infections that are caused by bacteria resistant to less toxic drugs (often by <i>Enterobacteriaceae</i> or <i>P. aeruginosa)</i></li></ul>

<p>Amikacin may be combined with a beta-lactam antibiotic for empiric therapy for people with neutropenia and fever.<span class="mw-ref" id="cite_ref-AHFS2016_4-10"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>Amikacin may be administered once or twice a day and is usually given by the intravenous or intramuscular route, though it can be given via nebulization. There is no oral form available, as amikacin is not absorbed orally. In people with kidney failure, dosage must be adjusted according to the creatinine clearance, usually by reducing the dosing frequency.<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-4"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> In people with a CNS infection such as meningitis, amikacin can be given intrathecally (by direct injection into the spine) or intraventricularly (by injection into the ventricles of brain).<span class="mw-ref" id="cite_ref-AHFS2016_4-11"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>An liposome inhalation suspension is also available and approved to treat Mycobacterium avium complex (MAC) in the United States.<span class="mw-ref" id="cite_ref-FDA_PR_15-0"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Arikayce_FDA_label_16-0"><a href="#cite_note-Arikayce_FDA_label-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> The application for Arikayce was withdrawn in the European Union because the Committee for Medicinal Products for Human Use (CHMP) was of the opinion that the benefits of Arikayce did not outweigh its risks.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Special_populations">Special populations</h3></summary>
    
<p>Amikacin should be used in smaller doses in the elderly, who often have age-related decreases in kidney function, and children, whose kidneys are not fully developed yet. It is considered pregnancy category D in both the United States and Australia, meaning they have a probability of harming the fetus.<span class="mw-ref" id="cite_ref-AHFS2016_4-12"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Around 16% of amikacin crosses the placenta; while the half-life of amikacin in the mother is 2 hours, it is 3.7 hours in the fetus.<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-5"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> A pregnant woman taking amikacin with another aminoglycoside has a possibility of causing congenital deafness in her child. While it is known to cross the placenta, amikacin is only partially secreted in breast milk.<span class="mw-ref" id="cite_ref-AHFS2016_4-13"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>In general, amikacin should be avoided in infants.<span class="mw-ref" id="cite_ref-ettinger_18-0"><a href="#cite_note-ettinger-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Infants also tend to have a larger volume of distribution due to their higher concentration of extracellular fluid, where aminoglycosides reside.<span class="mw-ref" id="cite_ref-plumb_3-1"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>The elderly tend to have amikacin stay longer in their system; while the average clearance of amikacin in a 20-year-old is 6 L/hr, it is 3 L/hr in an 80-year-old.<span class="mw-ref" id="cite_ref-maire_19-0"><a href="#cite_note-maire-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>Clearance is even higher in people with cystic fibrosis.<span class="mw-ref" id="cite_ref-eghianruwa_20-0"><a href="#cite_note-eghianruwa-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>In people with muscular disorders such as myasthenia gravis or Parkinson's disease, amikacin's paralytic effect on neuromuscular junctions can worsen muscle weakness.<span class="mw-ref" id="cite_ref-AHFS2016_4-14"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>Side-effects of amikacin are similar to those of other aminoglycosides. Kidney damage and ototoxicity (which can lead to hearing loss) are the most important effects, occurring in 1–10% of users.<span class="mw-ref" id="cite_ref-medscape_12-1"><a href="#cite_note-medscape-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> The nephro- and ototoxicity are thought to be due to aminoglycosides' tendency to accumulate in the kidneys and inner ear.<span class="mw-ref" id="cite_ref-plumb_3-2"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<div class="thumb tright"><div class="thumbinner" style="width:302px"><img src="../I/m/Gray920.png" tppabs="https://ptable.com/wiki/compounds/I/m/Gray920.png" data-file-width="500" data-file-height="365" data-file-type="bitmap" height="219" width="300"><div class="thumbcaption" style="text-align: left">Diagram of the inner ear. Amikacin causes damage to the cochlea and vestibules.</div></div></div>

<p>Amikacin can cause neurotoxicity if used at a higher dose or for longer than recommended. The resulting effects of neurotoxicity include vertigo, numbness, tingling of the skin (paresthesia), muscle twitching, and seizures.<span class="mw-ref" id="cite_ref-AHFS2016_4-15"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Its toxic effect on the 8th cranial nerve causes ototoxicity, resulting in loss of balance and, more commonly, hearing loss.<span class="mw-ref" id="cite_ref-plumb_3-3"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Damage to the cochlea, caused by the forced apoptosis of the hair cells, leads to the loss of high-frequency hearing and happens before any clinical hearing loss can be detected.<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-6"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-morris_21-0"><a href="#cite_note-morris-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Damage to the ear vestibules, most likely by creating excessive oxidative free radicals. It does so in a time-dependent rather than dose-dependent manner, meaning that risk can be minimized by reducing the duration of use.<span class="mw-ref" id="cite_ref-corti_22-0"><a href="#cite_note-corti-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>Amikacin causes nephrotoxicity (damage to the kidneys), by acting on the proximal renal tubules. It easily ionizes to a cation and binds to the anionic sites of the epithelial cells of the proximal tubule as part of receptor-mediated pinocytosis. The concentration of amikacin in the renal cortex becomes ten times that of amikacin in the plasma;<span class="mw-ref" id="cite_ref-ettinger_18-1"><a href="#cite_note-ettinger-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> it then most likely interferes with the metabolism of phospholipids in the lysosomes, which causes lytic enzymes to leak into the cytoplasm.<span class="mw-ref" id="cite_ref-plumb_3-4"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Nephrotoxicity results in increased serum <a href="Creatinine.htm" tppabs="https://ptable.com/wiki/compounds/A/Creatinine" title="Creatinine">creatinine</a>, blood urea nitrogen, red blood cells, and white blood cells, as well as albuminuria (increased output of albumin in the urine), glycosuria (excretion of glucose into the urine), decreased urine specific gravity, and oliguria (decrease in overall urine output).<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-7"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-morris_21-1"><a href="#cite_note-morris-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> It can also cause urinary casts to appear.<span class="mw-ref" id="cite_ref-plumb_3-5"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The changes in renal tubular function also change the electrolyte levels and acid-base balance in the body, which can lead to hypokalemia and acidosis or alkalosis.<span class="mw-ref" id="cite_ref-corti_22-1"><a href="#cite_note-corti-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> Nephrotoxicity is more common in those with pre-existing hypokalemia, hypocalcemia, hypomagnesemia, acidosis, low glomerular filtration rate, diabetes mellitus, dehydration, fever, and sepsis, as well as those taking antiprostaglandins.<span class="mw-ref" id="cite_ref-AHFS2016_4-16"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-ettinger_18-2"><a href="#cite_note-ettinger-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-plumb_3-6"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-corti_22-2"><a href="#cite_note-corti-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> The toxicity usually reverts once the antibiotic course has been completed,<span class="mw-ref" id="cite_ref-plumb_3-7"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> and can be avoided altogether by less frequent dosing (such as once every 24 hours rather than once every 8 hours).<span class="mw-ref" id="cite_ref-ettinger_18-3"><a href="#cite_note-ettinger-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Amikacin can cause neuromuscular blockade (including acute muscular paralysis) and respiratory paralysis (including apnea).<span class="mw-ref" id="cite_ref-AHFS2016_4-17"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Rare side effects (occurring in fewer than 1% of users) include allergic reactions, skin rash, fever, headaches, tremor, nausea and vomiting, eosinophilia, arthralgia, anemia, hypotension, and hypomagnesemia. In intravitreous injections (where amikacin is injected into the eye), macular infarction can cause permanent vision loss.<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-8"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-medscape_12-2"><a href="#cite_note-medscape-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>The amikacin liposome inhalation suspension prescribing information includes a boxed warning regarding the increased risk of respiratory conditions including hypersensitivity pneumonitis (inflamed lungs), bronchospasm (tightening of the airway), exacerbation of underlying lung disease and hemoptysis (spitting up blood) that have led to hospitalizations in some cases.<span class="mw-ref" id="cite_ref-FDA_PR_15-1"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Arikayce_FDA_label_16-1"><a href="#cite_note-Arikayce_FDA_label-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> Other common side effects in patients taking amikacin liposome inhalation suspension are dysphonia (difficulty speaking), cough, ototoxicity (damaged hearing), upper airway irritation, musculoskeletal pain, fatigue, diarrhea and nausea.<span class="mw-ref" id="cite_ref-FDA_PR_15-2"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Arikayce_FDA_label_16-2"><a href="#cite_note-Arikayce_FDA_label-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Amikacin should be avoided in those who are sensitive to <i>any</i> aminoglycoside, as they are cross-allergenic (that is, an allergy to one aminoglycoside also confers hypersensitivity to other aminoglycosides). It should also be avoided in those sensitive to sulfite (seen more among people with asthma),<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-9"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> since most amikacin usually comes with <a href="Sodium_metabisulfite.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_metabisulfite" title="Sodium metabisulfite">sodium metabisulfite</a>, which can cause an allergic reaction.<span class="mw-ref" id="cite_ref-AHFS2016_4-18"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>In general, amikacin should not be used with or just before/after another drug that can cause neurotoxicity, ototoxicity, or nephrotoxicity. Such drugs include other aminoglycosides; the antiviral <a href="Aciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Acyclovir" title="Acyclovir" class="mw-redirect">acyclovir</a>; the antifungal <a href="Amphotericin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphotericin_B" title="Amphotericin B">amphotericin B</a>; the antibiotics <a href="Bacitracin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bacitracin" title="Bacitracin">bacitracin</a>, <a href="Capreomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Capreomycin" title="Capreomycin">capreomycin</a>, colistin, <a href="Polymyxin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Polymyxin_B" title="Polymyxin B">polymyxin B</a>, and <a href="Vancomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Vancomycin" title="Vancomycin">vancomycin</a>; and <a href="Cisplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisplatin" title="Cisplatin">cisplatin</a>, which is used in chemotherapy.<span class="mw-ref" id="cite_ref-AHFS2016_4-19"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Amikacin should not be used with neuromuscular blocking agents, as they can increase muscle weakness and paralysis.<span class="mw-ref" id="cite_ref-AHFS2016_4-20"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Amikacin can be inactivated by other beta-lactams, though not to the extent as other aminoglycosides, and is still often used with penicillins (a type of beta-lactam) to create an additive effect against certain bacteria, and carbapenems, which can have a synergistic against some Gram-positive bacteria. Another group of beta-lactams, the cephalosporins, can increase the nephrotoxicity of aminoglycoside as well as randomly elevating <a href="Creatinine.htm" tppabs="https://ptable.com/wiki/compounds/A/Creatinine" title="Creatinine">creatinine</a> levels. The antibiotics <a href="Chloramphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloramphenicol" title="Chloramphenicol">chloramphenicol</a>, clindamycin, and <a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">tetracycline</a> have been known to inactivate aminoglycosides in general by pharmacological antagonism.<span class="mw-ref" id="cite_ref-AHFS2016_4-21"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>The effect of amikacin is increased when used with drugs derived from the <a href="Botulinum_toxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Botulinum_toxin" title="Botulinum toxin">botulinum toxin</a>,<span class="mw-ref" id="cite_ref-medscape_12-3"><a href="#cite_note-medscape-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> anesthetics, neuromuscular blocking agents, or large doses of blood that contains citrate as an anticoagulant.<span class="mw-ref" id="cite_ref-AHFS2016_4-22"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Potent diuretics not only cause ototoxicity themselves, but they can also increase the concentration of amikacin in the serum and tissue, making the ototoxicity even more likely.<span class="mw-ref" id="cite_ref-AHFS2016_4-23"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> <a href="Quinidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinidine" title="Quinidine">Quinidine</a> also increases levels of amikacin in the body.<span class="mw-ref" id="cite_ref-medscape_12-4"><a href="#cite_note-medscape-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> The NSAID <a href="Indometacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Indomethacin" title="Indomethacin" class="mw-redirect">indomethacin</a> can increase serum aminoglycoside levels in premature infants.<span class="mw-ref" id="cite_ref-AHFS2016_4-24"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Contrast mediums such as <a href="Ioversol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ioversol" title="Ioversol">ioversol</a> increases the nephrotoxicity and otoxicity caused by amikacin.<span class="mw-ref" id="cite_ref-medscape_12-5"><a href="#cite_note-medscape-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>Amikacin can decrease the effect certain vaccines, such as the live BCG vaccine (used for tuberculosis), the cholera vaccine, and the live typhoid vaccine by acting as a pharmacological antagonist.<span class="mw-ref" id="cite_ref-medscape_12-6"><a href="#cite_note-medscape-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/010_small_subunit-1FKA.gif" tppabs="https://ptable.com/wiki/compounds/I/m/010_small_subunit-1FKA.gif" data-file-width="320" data-file-height="320" data-file-type="bitmap" height="220" width="220"><div class="thumbcaption" style="text-align: left">The 30S subunit of the prokaryotic ribosome. The orange represents the 16S rRNA, and the blue represents the various proteins attached.</div></div></div>

<p>Amikacin irreversibly binds to 16S rRNA and the RNA-binding S12 protein of the 30S subunit of prokaryotic ribosome and inhibits protein synthesis by changing the ribosome's shape so that it cannot read the mRNA codons correctly.<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-10"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-bauman_23-0"><a href="#cite_note-bauman-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span>  It also interferes with the region that interacts with the wobble base of the tRNA anticodon.<span class="mw-ref" id="cite_ref-drugbank_24-0"><a href="#cite_note-drugbank-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> It works in a concentration-dependent manner, and has better action in an alkaline environment.<span class="mw-ref" id="cite_ref-plumb_3-8"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>At normal doses, amikacin-sensitive bacteria respond within 24–48 hours.<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-11"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Resistance">Resistance</h4></summary>
    
<p>Amikacin evades attacks by all antibiotic-inactivating enzymes that are responsible for antibiotic resistance in bacteria, except for aminoacetyltransferase and nucleotidyltransferase.<span class="mw-ref" id="cite_ref-mudd_25-0"><a href="#cite_note-mudd-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> This is accomplished by the <small>L</small>-hydroxyaminobuteroyl amide (L-HABA) moiety attached to N-1 (compare to <a href="Kanamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Kanamycin" title="Kanamycin" class="mw-redirect">kanamycin</a>, which simply has a hydrogen), which blocks the access and decreases the affinity of aminoglycoside-inactivating enzymes.<span class="mw-ref" id="cite_ref-mudd_25-1"><a href="#cite_note-mudd-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-kondo_26-0"><a href="#cite_note-kondo-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-park_27-0"><a href="#cite_note-park-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> Amikacin ends up with only one site where these enzymes can attack, while gentamicin and tobramycin have six.<span class="mw-ref" id="cite_ref-cunha_11-1"><a href="#cite_note-cunha-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Bacteria that are resistant to <a href="Streptomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Streptomycin" title="Streptomycin">streptomycin</a> and capreomycin are still susceptible to amikacin; bacteria that are resistant to kanamycin have varying susceptibility to amikacin. Resistance to amikacin also confers resistance to kanamycin and capreomycin.<span class="mw-ref" id="cite_ref-caminero_28-0"><a href="#cite_note-caminero-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>

<p>Resistance to amikacin and kanamycin in <i>Mycobacterium</i>, the causative agent of tuberculosis, is due to a mutation in the <i>rrs</i> gene, which codes for the 16S rRNA. Mutations such as these reduce the binding affinity of amikacin to the bacteria's ribosome.<span class="mw-ref" id="cite_ref-ahmad_29-0"><a href="#cite_note-ahmad-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> Variations of aminoglycoside acetyltransferase (AAC) and aminoglycoside adenylyltransferase (AAD) also confer resistance: resistance in <i>Pseudomonas aeruginosa</i> is caused by AAC(6')-IV, which also confers resistance to kanamycin, gentamicin, and tobramycin, and resistance in <i>Staphylococcus aureus</i> and <i>S. epidermidis</i> is caused by AAD(4',4<i>), </i>which also confers resistance to kanamycin, tobramycin, and apramycin.<span class="mw-ref" id="cite_ref-kondo_26-1"><a href="#cite_note-kondo-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> Some strains of <i>S. aureus</i> can also inactivate amikacin by phosphorylating it.<span class="mw-ref" id="cite_ref-aronson_13-1"><a href="#cite_note-aronson-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Amikacin is not absorbed orally and thus must be administered parenterally. It reaches peak serum concentrations in 0.5–2 hours when administered intramuscularly. Less than 11% of the amikacin actually binds to plasma proteins. It is distributed into the heart, gallbladder, lungs, and bones, as well as in bile, sputum, interstitial fluid, pleural fluid, and synovial fluids. It is usually found at low concentrations in the cerebrospinal fluid, except when administered intraventricularly.<span class="mw-ref" id="cite_ref-AHFS2016_4-25"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In infants, amikacin is normally found at 10–20% of plasma levels in the spinal fluid, but the amount reaches 50% in cases of meningitis.<span class="mw-ref" id="cite_ref-Amikacin_sulfate_FDA_label_9-12"><a href="#cite_note-Amikacin_sulfate_FDA_label-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It does not easily cross the blood-brain barrier or enter ocular tissue.<span class="mw-ref" id="cite_ref-plumb_3-9"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>While the half-life of amikacin is normally two hours, it is 50 hours in those with end-stage renal disease.<span class="mw-ref" id="cite_ref-cunha_11-2"><a href="#cite_note-cunha-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>The vast majority (95%) of amikacin from an IM or IV dose is secreted unchanged via glomerular filtration and into the urine within 24 hours.<span class="mw-ref" id="cite_ref-AHFS2016_4-26"><a href="#cite_note-AHFS2016-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-cunha_11-3"><a href="#cite_note-cunha-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Factors that cause amikacin to be excreted via urine include its relatively low molecular weight, high water solubility, and unmetabolized state.<span class="mw-ref" id="cite_ref-ettinger_18-4"><a href="#cite_note-ettinger-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>Amikacin is derived from kanamycin A:<span class="mw-ref" id="cite_ref-kawaguchi_30-0"><a href="#cite_note-kawaguchi-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-monteleone_31-0"><a href="#cite_note-monteleone-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>

<center><div class="thumb tnone"></div><div class="thumbinner" style="width:802px"><img src="../I/m/Amikacin_synthesis_2.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Amikacin_synthesis_2.svg.png" data-file-width="685" data-file-height="503" data-file-type="drawing" height="587" width="800"><div class="thumbcaption" style="text-align: left">The synthesis of amikacin</div></div></center>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Veterinary_use">Veterinary use</h2></summary>
    
<p>While amikacin is only FDA-approved for use in dogs and for intrauterine infection in horses, it is one of the most common aminoglycosides used in veterinary medicine,<span class="mw-ref" id="cite_ref-forney_32-0"><a href="#cite_note-forney-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> and has been used in dogs, cats, guinea pigs, chinchillas, hamsters, rats, mice, prairie dogs, cattle, birds, snakes, turtles and tortoises, crocodilians, bullfrogs, and fish.<span class="mw-ref" id="cite_ref-plumb_3-10"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-33"><a href="#cite_note-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> It is often used for respiratory infections in snakes, bacterial shell disease in turtles, and sinusitis in macaws. It is generally contraindicated in rabbits and hares (though it has still been used) because it harms the balance of intestinal microflora.<span class="mw-ref" id="cite_ref-plumb_3-11"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>In dogs and cats, amikacin is commonly used as a topical antibiotic for ear infections and for corneal ulcers, especially those that are caused by <i>Pseudomonas aeruginosa</i>. The ears are often cleaned before administering the medication, since pus and cellular debris lessen the activity of amikacin.<span class="mw-ref" id="cite_ref-forney_32-1"><a href="#cite_note-forney-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Amikacin is administered to the eye when prepared as an ophthalmic ointment or solution, or when injected subconjunctivally.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> Amikacin in the eye can be accompanied by <a href="Cefazolin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephazolin" title="Cephazolin" class="mw-redirect">cephazolin</a>. Despite its use there amikacin (and all aminoglycosides) are toxic to intraocular structures.<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>

<p>In horses, amikacin is FDA-approved for uterine infections (such as endometriosis and pyometra) when caused by susceptible bacteria.<span class="mw-ref" id="cite_ref-Amiglyde-V_FDA_label_37-0"><a href="#cite_note-Amiglyde-V_FDA_label-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> It is also used in topical medication for the eyes and arthroscopic lavage; when combined with a cephalosporin, is used to treat subcutaneous infections that are caused by <i>Staphylococcus</i>. For infections in the limbs or joints, it is often administered with a cephalosporin via limb perfusion directly into the limb or injected into the joint.<span class="mw-ref" id="cite_ref-forney_32-2"><a href="#cite_note-forney-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-orsini_38-0"><a href="#cite_note-orsini-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Amikacin is also injected into the joints with the anti-arthritic medication Adequan in order to prevent infection.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>

<p>Side effects in animals include nephrotoxicity, ototoxicity, and allergic reactions at IM injection sites. Cats tend to be more sensitive to the vestibular damage caused by ototoxicity. Less frequent side effects include neuromuscular blockade, facial edema, and peripheral neuropathy.<span class="mw-ref" id="cite_ref-plumb_3-12"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-forney_32-3"><a href="#cite_note-forney-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>

<p>The half-life in most animals is one to two hours.<span class="mw-ref" id="cite_ref-papich_40-0"><a href="#cite_note-papich-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>

<p>Treating overdoses of amikacin requires kidney dialysis or peritoneal dialysis, which reduce serum concentrations of amikacin, and/or penicillins, some of which can form complexes with amikacin that deactivate it.<span class="mw-ref" id="cite_ref-plumb_3-13"><a href="#cite_note-plumb-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Liposome_inhalation_suspension">Liposome inhalation suspension</h2></summary>
    

<p>Amikacin liposome inhalation suspension was the first drug approved under the US <span class="new">limited population pathway for antibacterial and antifungal drugs</span> (LPAD pathway).<span class="mw-ref" id="cite_ref-FDA_PR_15-3"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> It also was approved under the accelerated approval pathway.<span class="mw-ref" id="cite_ref-FDA_PR_15-4"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> The U.S. Food and Drug Administration (FDA) granted the application for amikacin liposome inhalation suspension fast track, breakthrough therapy, priority review, and qualified infectious disease product (QIDP) designations.<span class="mw-ref" id="cite_ref-FDA_PR_15-5"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> The FDA granted approval of Arikayce to Insmed, Inc.<span class="mw-ref" id="cite_ref-FDA_PR_15-6"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>The safety and efficacy of amikacin liposome inhalation suspension, an inhaled treatment taken through a nebulizer, was demonstrated in a randomized, controlled clinical trial where patients were assigned to one of two treatment groups.<span class="mw-ref" id="cite_ref-FDA_PR_15-7"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> One group of patients received amikacin liposome inhalation suspension plus a background multi-drug antibacterial regimen, while the other treatment group received a background multi-drug antibacterial regimen alone.<span class="mw-ref" id="cite_ref-FDA_PR_15-8"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> By the sixth month of treatment, 29 percent of patients treated with amikacin liposome inhalation suspension had no growth of mycobacteria in their sputum cultures for three consecutive months compared to 9 percent of patients who were not treated with amikacin liposome inhalation suspension.<span class="mw-ref" id="cite_ref-FDA_PR_15-9"><a href="#cite_note-FDA_PR-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/amikacin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/amikacin.html'" tppabs="https://www.drugs.com/pregnancy/amikacin.html" class="external text external">"Amikacin Use During Pregnancy"</a>. <i>Drugs.com</i>. 2 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2020</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/medicine/619  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/medicine/619'" tppabs="https://www.medicines.org.uk/emc/medicine/619" class="external text external">"Amikacin 250 mg/ml Injection - Summary of Product Characteristics (SmPC)"</a>. <i>(emc)</i>. 16 September 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2020</span>.</cite></span></li><li id="cite_note-plumb-3"> <span id="mw-reference-text-cite_note-plumb-3" class="mw-reference-text"><cite id="CITEREFPlumb2011" class="citation book cs1">Plumb, Donald C. (2011). "Amikacin Sulfate". <i>Plumb's Veterinary Drug Handbook</i> (7th ed.). Stockholm, Wisconsin; Ames, Iowa: Wiley. pp.<span>&nbsp;</span>39–43. ISBN<span>&nbsp;</span><bdi>978-0-470-95964-0</bdi>.</cite></span></li><li id="cite_note-AHFS2016-4"> <span id="mw-reference-text-cite_note-AHFS2016-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/amikacin-sulfate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/amikacin-sulfate.html'" tppabs="https://www.drugs.com/monograph/amikacin-sulfate.html" class="external text external">"Amikacin Sulfate"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20161220231044/https://www.drugs.com/monograph/amikacin-sulfate.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161220231044/https://www.drugs.com/monograph/amikacin-sulfate.html'" tppabs="https://web.archive.org/web/20161220231044/https://www.drugs.com/monograph/amikacin-sulfate.html" class="external text external">Archived</a> from the original on 20 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">8 December</span> 2016</span>.</cite></span></li><li id="cite_note-WHO2008-5"> <span id="mw-reference-text-cite_note-WHO2008-5" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2009" class="citation book cs1">World Health Organization (2009).  Stuart MC, Kouimtzi M, Hill SR (eds.). <i>WHO Model Formulary 2008</i>. World Health Organization. p.<span>&nbsp;</span>137. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F44053  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F44053'" tppabs="https://hdl.handle.net/10665%2F44053" class="external text external">10665/44053</a></span>. ISBN<span>&nbsp;</span><bdi>9789241547659</bdi>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Janos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA507  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA507'" tppabs="https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA507" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>507. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20161220092307/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA507  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161220092307/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA507'" tppabs="https://web.archive.org/web/20161220092307/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA507" class="external text external">Archived</a> from the original on 20 December 2016.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.ca/books?id=5W-WBQAAQBAJ&pg=PT56  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=5W-WBQAAQBAJ&pg=PT56'" tppabs="https://books.google.ca/books?id=5W-WBQAAQBAJ&pg=PT56" class="external text external"><i>Oxford Handbook of Infectious Diseases and Microbiology</i></a>. OUP Oxford. 2009. p.<span>&nbsp;</span>56. ISBN<span>&nbsp;</span><bdi>9780191039621</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20151124232554/https://books.google.ca/books?id=5W-WBQAAQBAJ&pg=PT56  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151124232554/https://books.google.ca/books?id=5W-WBQAAQBAJ&pg=PT56'" tppabs="https://web.archive.org/web/20151124232554/https://books.google.ca/books?id=5W-WBQAAQBAJ&pg=PT56" class="external text external">Archived</a> from the original on 24 November 2015.</cite></span></li><li id="cite_note-WHO21st-8"> <span id="mw-reference-text-cite_note-WHO21st-8" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-Amikacin_sulfate_FDA_label-9"> <span id="mw-reference-text-cite_note-Amikacin_sulfate_FDA_label-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0f57839-1c9b-49e5-8c7a-708e2d16495d  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0f57839-1c9b-49e5-8c7a-708e2d16495d'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0f57839-1c9b-49e5-8c7a-708e2d16495d" class="external text external">"Amikacin sulfate injection, solution"</a>. <i>DailyMed</i>. 10 April 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2020</span>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFScholarPratt2000" class="citation book cs1">Scholar, Eric M.; Pratt, William B. (22 May 2000). <a href="javascript:if(confirm('https://books.google.com/books?id=gACeB8XCnpgC&pg=PA15  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=gACeB8XCnpgC&pg=PA15'" tppabs="https://books.google.com/books?id=gACeB8XCnpgC&pg=PA15" class="external text external"><i>The Antimicrobial Drugs</i></a> (2nd ed.). Oxford University Press, USA. pp.<span>&nbsp;</span>15–19. ISBN<span>&nbsp;</span><bdi>978-0-19-975971-2</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172330/https://books.google.com/books?id=gACeB8XCnpgC&pg=PA15  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172330/https://books.google.com/books?id=gACeB8XCnpgC&pg=PA15'" tppabs="https://web.archive.org/web/20170910172330/https://books.google.com/books?id=gACeB8XCnpgC&pg=PA15" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-cunha-11"> <span id="mw-reference-text-cite_note-cunha-11" class="mw-reference-text"><cite id="CITEREFCunha2006" class="citation journal cs1">Cunha, Burke A. (1 November 2006). "New Uses for Older Antibiotics: Nitrofurantoin, Amikacin, Colistin, Polymyxin B, Doxycycline, and Minocycline Revisited". <i>Medical Clinics of North America</i>. Antimicrobial Therapy. <b>90</b> (6): 1089–1107. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.mcna.2006.07.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.mcna.2006.07.006'" tppabs="https://doi.org/10.1016%2Fj.mcna.2006.07.006" class="external text external">10.1016/j.mcna.2006.07.006</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0025-7125  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0025-7125'" tppabs="https://www.worldcat.org/issn/0025-7125" class="external text external">0025-7125</a>.</cite></span></li><li id="cite_note-medscape-12"> <span id="mw-reference-text-cite_note-medscape-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://reference.medscape.com/drug/amikin-amikacin-342516  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://reference.medscape.com/drug/amikin-amikacin-342516#0'" tppabs="http://reference.medscape.com/drug/amikin-amikacin-342516#0" class="external text external">"amikacin (Rx)"</a>. <i>Medscape</i>. WebMD. <a href="javascript:if(confirm('https://web.archive.org/web/20170809083119/http://reference.medscape.com/drug/amikin-amikacin-342516  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170809083119/http://reference.medscape.com/drug/amikin-amikacin-342516'" tppabs="https://web.archive.org/web/20170809083119/http://reference.medscape.com/drug/amikin-amikacin-342516" class="external text external">Archived</a> from the original on 9 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">9 August</span> 2017</span>.</cite></span></li><li id="cite_note-aronson-13"> <span id="mw-reference-text-cite_note-aronson-13" class="mw-reference-text"><cite id="CITEREFAronson_J._K.2016" class="citation book cs1">Aronson J. K., ed. (2016). "Amikacin". <i>Meyler's Side Effects of Drugs</i> (16th ed.). Oxford: Elsevier. pp.<span>&nbsp;</span>207–209. ISBN<span>&nbsp;</span><bdi>978-0-444-53716-4</bdi>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFVardanyanHruby2016" class="citation book cs1">Vardanyan, Ruben; Hruby, Victor (2016). "Chapter 32: Antimicobacterial Drugs". <i>Synthesis of Best-Seller Drugs</i>. Boston: Academic Press. pp.<span>&nbsp;</span>669–675. ISBN<span>&nbsp;</span><bdi>978-0-12-411492-0</bdi>.</cite></span></li><li id="cite_note-FDA_PR-15"> <span id="mw-reference-text-cite_note-FDA_PR-15" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibacterial-drug-treat-serious-lung-disease-using-novel-pathway-spur-innovation  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibacterial-drug-treat-serious-lung-disease-using-novel-pathway-spur-innovation'" tppabs="https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibacterial-drug-treat-serious-lung-disease-using-novel-pathway-spur-innovation" class="external text external">"FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation"</a>. <i>U.S. Food and Drug Administration (FDA)</i> (Press release)<span class="reference-accessdate">. Retrieved <span class="nowrap">12 November</span> 2018</span>.</cite> <figure-inline><span><img src="../I/m/PD-icon.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/PD-icon.svg.png" data-file-width="196" data-file-height="196" data-file-type="drawing" height="15" width="15"></span></figure-inline><span> </span><i>This article incorporates text from this source, which is in the public domain.</i></span></li><li id="cite_note-Arikayce_FDA_label-16"> <span id="mw-reference-text-cite_note-Arikayce_FDA_label-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=499ab990-2b21-474f-aaba-d86388965f40  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=499ab990-2b21-474f-aaba-d86388965f40'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=499ab990-2b21-474f-aaba-d86388965f40" class="external text external">"Arikayce- amikacin suspension"</a>. <i>DailyMed</i>. 30 September 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2020</span>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/arikayce  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/arikayce'" tppabs="https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/arikayce" class="external text external">"Arikayce: Withdrawn application"</a>. <i>European Medicines Agency (EMA)</i>. 14 October 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">13 March</span> 2020</span>.</cite></span></li><li id="cite_note-ettinger-18"> <span id="mw-reference-text-cite_note-ettinger-18" class="mw-reference-text"><cite id="CITEREFEttingerFeldman2009" class="citation book cs1">Ettinger, Stephen J.; Feldman, Edward C. (24 December 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=4Qzau1jagOYC&pg=PA1976  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=4Qzau1jagOYC&pg=PA1976'" tppabs="https://books.google.com/books?id=4Qzau1jagOYC&pg=PA1976" class="external text external"><i>Textbook of Veterinary Internal Medicine</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>1976, 523. ISBN<span>&nbsp;</span><bdi>978-1-4377-0282-8</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172330/https://books.google.com/books?id=4Qzau1jagOYC&pg=PA1976  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172330/https://books.google.com/books?id=4Qzau1jagOYC&pg=PA1976'" tppabs="https://web.archive.org/web/20170910172330/https://books.google.com/books?id=4Qzau1jagOYC&pg=PA1976" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-maire-19"> <span id="mw-reference-text-cite_note-maire-19" class="mw-reference-text"><cite id="CITEREFMaireBourguignonGoutelleDucher2017" class="citation book cs1">Maire, P.; Bourguignon, L.; Goutelle, S.; Ducher, M.; Jelliffe, R. (2017). "Chapter 20 - Individualizing Drug Therapy in the Elderly". <i>Individualized Drug Therapy for Patients</i>. Boston: Academic Press. pp.<span>&nbsp;</span>373–382. ISBN<span>&nbsp;</span><bdi>978-0-12-803348-7</bdi>.</cite></span></li><li id="cite_note-eghianruwa-20"> <span id="mw-reference-text-cite_note-eghianruwa-20" class="mw-reference-text"><cite id="CITEREFEghianruwa2014" class="citation book cs1">Eghianruwa, Kingsley (2014). <a href="javascript:if(confirm('https://books.google.com/books?id=h4zCAgAAQBAJ&pg=PA16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=h4zCAgAAQBAJ&pg=PA16'" tppabs="https://books.google.com/books?id=h4zCAgAAQBAJ&pg=PA16" class="external text external"><i>Essential Drug Data for Rational Therapy in Veterinary Practice</i></a>. Author House. p.<span>&nbsp;</span>16. ISBN<span>&nbsp;</span><bdi>978-1-4918-0000-3</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172330/https://books.google.com/books?id=h4zCAgAAQBAJ&pg=PA16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172330/https://books.google.com/books?id=h4zCAgAAQBAJ&pg=PA16'" tppabs="https://web.archive.org/web/20170910172330/https://books.google.com/books?id=h4zCAgAAQBAJ&pg=PA16" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-morris-21"> <span id="mw-reference-text-cite_note-morris-21" class="mw-reference-text"><cite id="CITEREFMorrisKennis2012" class="citation book cs1">Morris, Daniel O.; Kennis, Robert A. (11 October 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=TsKQVAWxHg4C&pg=PA29  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=TsKQVAWxHg4C&pg=PA29'" tppabs="https://books.google.com/books?id=TsKQVAWxHg4C&pg=PA29" class="external text external"><i>Clinical Dermatology, An Issue of Veterinary Clinics: Small Animal Practice, E-Book</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>29. ISBN<span>&nbsp;</span><bdi>978-1-4557-7377-0</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172330/https://books.google.com/books?id=TsKQVAWxHg4C&pg=PA29  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172330/https://books.google.com/books?id=TsKQVAWxHg4C&pg=PA29'" tppabs="https://web.archive.org/web/20170910172330/https://books.google.com/books?id=TsKQVAWxHg4C&pg=PA29" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-corti-22"> <span id="mw-reference-text-cite_note-corti-22" class="mw-reference-text"><cite id="CITEREFCortiTaegtmeyerImhof2011" class="citation journal cs1">Corti, Natascia; Taegtmeyer, Anne; Imhof, Alexander (1 January 2011). "Miscellaneous antibacterial drugs". <i>Side Effects of Drugs Annual</i>. A worldwide yearly survey of new data in adverse drug reactions. <b>33</b>: 509–540. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FB978-0-444-53741-6.00026-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FB978-0-444-53741-6.00026-X'" tppabs="https://doi.org/10.1016%2FB978-0-444-53741-6.00026-X" class="external text external">10.1016/B978-0-444-53741-6.00026-X</a>. ISBN<span>&nbsp;</span><bdi>9780444537416</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0378-6080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0378-6080'" tppabs="https://www.worldcat.org/issn/0378-6080" class="external text external">0378-6080</a>.</cite></span></li><li id="cite_note-bauman-23"> <span id="mw-reference-text-cite_note-bauman-23" class="mw-reference-text"><cite id="CITEREFBauman2015" class="citation book cs1">Bauman, Robert W. (2015). <i>Microbiology: with diseases by body system</i> (4th ed.). Boston: Pearson. ISBN<span>&nbsp;</span><bdi>978-0-321-91855-0</bdi>.</cite></span></li><li id="cite_note-drugbank-24"> <span id="mw-reference-text-cite_note-drugbank-24" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00479'" tppabs="https://www.drugbank.ca/drugs/DB00479" class="external text external">"Amikacin"</a>. <i>DrugBank</i>. 2 August 2017. <a href="javascript:if(confirm('https://web.archive.org/web/20170816150102/https://www.drugbank.ca/drugs/DB00479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170816150102/https://www.drugbank.ca/drugs/DB00479'" tppabs="https://web.archive.org/web/20170816150102/https://www.drugbank.ca/drugs/DB00479" class="external text external">Archived</a> from the original on 16 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">10 August</span> 2017</span>.</cite></span></li><li id="cite_note-mudd-25"> <span id="mw-reference-text-cite_note-mudd-25" class="mw-reference-text"><cite id="CITEREFMudd2017" class="citation web cs1">Mudd, Efrain (7 August 2017). <a href="javascript:if(confirm('https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/o-aminoglycosides.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/o-aminoglycosides.html'" tppabs="https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/o-aminoglycosides.html" class="external text external">"O Aminoglycosides"</a>. <i>Pharmacological Sciences</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20170816105922/https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/o-aminoglycosides.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170816105922/https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/o-aminoglycosides.html'" tppabs="https://web.archive.org/web/20170816105922/https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/o-aminoglycosides.html" class="external text external">Archived</a> from the original on 16 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">14 August</span> 2017</span>.</cite></span></li><li id="cite_note-kondo-26"> <span id="mw-reference-text-cite_note-kondo-26" class="mw-reference-text"><cite id="CITEREFKondoHotta1999" class="citation journal cs1">Kondo, Shinichi; Hotta, Kunimoto (1 January 1999). "Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications". <i>Journal of Infection and Chemotherapy</i>. <b>5</b> (1): 1–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs101560050001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs101560050001'" tppabs="https://doi.org/10.1007%2Fs101560050001" class="external text external">10.1007/s101560050001</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1341-321X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1341-321X'" tppabs="https://www.worldcat.org/issn/1341-321X" class="external text external">1341-321X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11810483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11810483'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11810483" class="external text external">11810483</a>.</cite></span></li><li id="cite_note-park-27"> <span id="mw-reference-text-cite_note-park-27" class="mw-reference-text"><cite id="CITEREFParkBanNamCha2017" class="citation journal cs1">Park, Je Won; Ban, Yeon Hee; Nam, Sang-Jip; Cha, Sun-Shin; Yoon, Yeo Joon (1 December 2017). "Biosynthetic pathways of aminoglycosides and their engineering". <i>Current Opinion in Biotechnology</i>. Chemical biotechnology: Pharmaceutical biotechnology. <b>48</b>: 33–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.copbio.2017.03.019  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.copbio.2017.03.019'" tppabs="https://doi.org/10.1016%2Fj.copbio.2017.03.019" class="external text external">10.1016/j.copbio.2017.03.019</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0958-1669  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0958-1669'" tppabs="https://www.worldcat.org/issn/0958-1669" class="external text external">0958-1669</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28365471  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28365471'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28365471" class="external text external">28365471</a>.</cite></span></li><li id="cite_note-caminero-28"> <span id="mw-reference-text-cite_note-caminero-28" class="mw-reference-text"><cite id="CITEREFCamineroSotgiuZumlaMigliori2010" class="citation journal cs1">Caminero, José A; Sotgiu, Giovanni; Zumla, Alimuddin; Migliori, Giovanni Battista (1 September 2010). <a href="javascript:if(confirm('https://www.researchgate.net/profile/Alimuddin_Zumla/publication/46008880_Best_drug_treatment_for_multidrug-resistant_and_extensively_drug-resistant_tuberculosis._The_Lancet_Infectious_Diseases_10_621-629/links/0912f5077d00053a31000000.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.researchgate.net/profile/Alimuddin_Zumla/publication/46008880_Best_drug_treatment_for_multidrug-resistant_and_extensively_drug-resistant_tuberculosis._The_Lancet_Infectious_Diseases_10_621-629/links/0912f5077d00053a31000000.pdf'" tppabs="https://www.researchgate.net/profile/Alimuddin_Zumla/publication/46008880_Best_drug_treatment_for_multidrug-resistant_and_extensively_drug-resistant_tuberculosis._The_Lancet_Infectious_Diseases_10_621-629/links/0912f5077d00053a31000000.pdf" class="external text external">"Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis"</a> <span class="cs1-format">(PDF)</span>. <i>The Lancet Infectious Diseases</i>. <b>10</b> (9): 621–629. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1473-3099%2810%2970139-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1473-3099%2810%2970139-0'" tppabs="https://doi.org/10.1016%2FS1473-3099%2810%2970139-0" class="external text external">10.1016/S1473-3099(10)70139-0</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1473-3099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1473-3099'" tppabs="https://www.worldcat.org/issn/1473-3099" class="external text external">1473-3099</a>.</cite></span></li><li id="cite_note-ahmad-29"> <span id="mw-reference-text-cite_note-ahmad-29" class="mw-reference-text"><cite id="CITEREFAhmadMokaddas2014" class="citation journal cs1">Ahmad, Suhail; Mokaddas, Eiman (1 March 2014). <a href="javascript:if(confirm('https://doi.org/10.1016/j.jiph.2013.09.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016/j.jiph.2013.09.001'" tppabs="https://doi.org/10.1016/j.jiph.2013.09.001" class="external text external">"Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis"</a>. <i>Journal of Infection and Public Health</i>. <b>7</b> (2): 75–91. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jiph.2013.09.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jiph.2013.09.001'" tppabs="https://doi.org/10.1016%2Fj.jiph.2013.09.001" class="external text external">10.1016/j.jiph.2013.09.001</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1876-0341  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1876-0341'" tppabs="https://www.worldcat.org/issn/1876-0341" class="external text external">1876-0341</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24216518  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24216518'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24216518" class="external text external">24216518</a>.</cite></span></li><li id="cite_note-kawaguchi-30"> <span id="mw-reference-text-cite_note-kawaguchi-30" class="mw-reference-text"><cite id="CITEREFKawaguchiNaitoNakagawaFujisawa1972" class="citation journal cs1">Kawaguchi, H.; Naito, T.; Nakagawa, S.; Fujisawa, K. I. (December 1972). <a href="javascript:if(confirm('https://www.jstage.jst.go.jp/article/antibiotics1968/25/12/25_12_695/_pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.jstage.jst.go.jp/article/antibiotics1968/25/12/25_12_695/_pdf'" tppabs="https://www.jstage.jst.go.jp/article/antibiotics1968/25/12/25_12_695/_pdf" class="external text external">"BB-K 8, a new semisynthetic aminoglycoside antibiotic"</a>. <i>The Journal of Antibiotics</i>. <b>25</b> (12): 695–708. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.7164%2Fantibiotics.25.695  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7164%2Fantibiotics.25.695'" tppabs="https://doi.org/10.7164%2Fantibiotics.25.695" class="external text external">10.7164/antibiotics.25.695</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0021-8820  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0021-8820'" tppabs="https://www.worldcat.org/issn/0021-8820" class="external text external">0021-8820</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4568692  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4568692'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4568692" class="external text external">4568692</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20170816105728/https://www.jstage.jst.go.jp/article/antibiotics1968/25/12/25_12_695/_pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170816105728/https://www.jstage.jst.go.jp/article/antibiotics1968/25/12/25_12_695/_pdf'" tppabs="https://web.archive.org/web/20170816105728/https://www.jstage.jst.go.jp/article/antibiotics1968/25/12/25_12_695/_pdf" class="external text external">Archived</a> from the original on 16 August 2017.</cite></span></li><li id="cite_note-monteleone-31"> <span id="mw-reference-text-cite_note-monteleone-31" class="mw-reference-text"><cite id="CITEREFMonteleoneMuhammadBrownMcGrory1983" class="citation journal cs1">Monteleone, Peter M.; Muhammad, Naseem; Brown, Robert D.; McGrory, John P.; Hanna, Samir A. (1 January 1983). "Amikacin Sulfate". <i>Analytical Profiles of Drug Substances</i>. Analytical Profiles of Drug Substances. <b>12</b>: 37–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0099-5428%2808%2960163-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0099-5428%2808%2960163-X'" tppabs="https://doi.org/10.1016%2FS0099-5428%2808%2960163-X" class="external text external">10.1016/S0099-5428(08)60163-X</a>. ISBN<span>&nbsp;</span><bdi>9780122608124</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0099-5428  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0099-5428'" tppabs="https://www.worldcat.org/issn/0099-5428" class="external text external">0099-5428</a>.</cite></span></li><li id="cite_note-forney-32"> <span id="mw-reference-text-cite_note-forney-32" class="mw-reference-text"><cite id="CITEREFForney" class="citation web cs1">Forney, Barbara. <a href="javascript:if(confirm('http://www.wedgewoodpetrx.com/learning-center/professional-monographs/amikacin-for-veterinary-use.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.wedgewoodpetrx.com/learning-center/professional-monographs/amikacin-for-veterinary-use.html'" tppabs="http://www.wedgewoodpetrx.com/learning-center/professional-monographs/amikacin-for-veterinary-use.html" class="external text external">"Amikacin for Veterinary Use"</a>. <i>Wedgewood Pharmacy</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20170816110344/http://www.wedgewoodpetrx.com/learning-center/professional-monographs/amikacin-for-veterinary-use.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170816110344/http://www.wedgewoodpetrx.com/learning-center/professional-monographs/amikacin-for-veterinary-use.html'" tppabs="https://web.archive.org/web/20170816110344/http://www.wedgewoodpetrx.com/learning-center/professional-monographs/amikacin-for-veterinary-use.html" class="external text external">Archived</a> from the original on 16 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">9 August</span> 2017</span>.</cite></span></li><li id="cite_note-33"> <span id="mw-reference-text-cite_note-33" class="mw-reference-text"><cite id="CITEREFRivierePapich2013" class="citation book cs1">Riviere, Jim E.; Papich, Mark G. (13 May 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=xAPa4WDzAnQC&pg=PA931  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=xAPa4WDzAnQC&pg=PA931'" tppabs="https://books.google.com/books?id=xAPa4WDzAnQC&pg=PA931" class="external text external"><i>Veterinary Pharmacology and Therapeutics</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>931. ISBN<span>&nbsp;</span><bdi>978-1-118-68590-7</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172330/https://books.google.com/books?id=xAPa4WDzAnQC&pg=PA931  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172330/https://books.google.com/books?id=xAPa4WDzAnQC&pg=PA931'" tppabs="https://web.archive.org/web/20170910172330/https://books.google.com/books?id=xAPa4WDzAnQC&pg=PA931" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite id="CITEREFMaderDivers2013" class="citation book cs1">Mader, Douglas R.; Divers, Stephen J. (12 December 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=2phWAgAAQBAJ&pg=PA382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=2phWAgAAQBAJ&pg=PA382'" tppabs="https://books.google.com/books?id=2phWAgAAQBAJ&pg=PA382" class="external text external"><i>Current Therapy in Reptile Medicine and Surgery - E-Book</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>382. ISBN<span>&nbsp;</span><bdi>978-0-323-24293-6</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172330/https://books.google.com/books?id=2phWAgAAQBAJ&pg=PA382  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172330/https://books.google.com/books?id=2phWAgAAQBAJ&pg=PA382'" tppabs="https://web.archive.org/web/20170910172330/https://books.google.com/books?id=2phWAgAAQBAJ&pg=PA382" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite id="CITEREFMaggsMillerOfri2013" class="citation book cs1">Maggs, David; Miller, Paul; Ofri, Ron (7 August 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=8QCduRN3zR0C&pg=PA37  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=8QCduRN3zR0C&pg=PA37'" tppabs="https://books.google.com/books?id=8QCduRN3zR0C&pg=PA37" class="external text external"><i>Slatter's Fundamentals of Veterinary Ophthalmology - E-Book</i></a>. Elsevier Health Sciences. p.<span>&nbsp;</span>37. ISBN<span>&nbsp;</span><bdi>978-0-323-24196-0</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172330/https://books.google.com/books?id=8QCduRN3zR0C&pg=PA37  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172330/https://books.google.com/books?id=8QCduRN3zR0C&pg=PA37'" tppabs="https://web.archive.org/web/20170910172330/https://books.google.com/books?id=8QCduRN3zR0C&pg=PA37" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFHsu2013" class="citation book cs1">Hsu, Walter H. (25 April 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=MGhScg9GZGAC&pg=PT486  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=MGhScg9GZGAC&pg=PT486'" tppabs="https://books.google.com/books?id=MGhScg9GZGAC&pg=PT486" class="external text external"><i>Handbook of Veterinary Pharmacology</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>486. ISBN<span>&nbsp;</span><bdi>978-1-118-71416-4</bdi>.</cite></span></li><li id="cite_note-Amiglyde-V_FDA_label-37"> <span id="mw-reference-text-cite_note-Amiglyde-V_FDA_label-37" class="mw-reference-text"><cite id="CITEREFUS_National_Library_of_Medicine2017" class="citation web cs1">US National Library of Medicine (9 March 2017). <a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2abecaf-9532-45a0-a284-5697b2aa38f1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2abecaf-9532-45a0-a284-5697b2aa38f1'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2abecaf-9532-45a0-a284-5697b2aa38f1" class="external text external">"Amiglyde-V- amikacin sulfate injection"</a>. <i>DailyMed</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20170816110928/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2abecaf-9532-45a0-a284-5697b2aa38f1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170816110928/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2abecaf-9532-45a0-a284-5697b2aa38f1'" tppabs="https://web.archive.org/web/20170816110928/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2abecaf-9532-45a0-a284-5697b2aa38f1" class="external text external">Archived</a> from the original on 16 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">8 August</span> 2017</span>.</cite></span></li><li id="cite_note-orsini-38"> <span id="mw-reference-text-cite_note-orsini-38" class="mw-reference-text"><cite id="CITEREFOrsini2017" class="citation journal cs1">Orsini, James A. (1 August 2017). "Update on Managing Serious Wound Infections in Horses: Wounds Involving Joints and Other Synovial Structures". <i>Journal of Equine Veterinary Science</i>. <b>55</b>: 115–122. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jevs.2017.01.016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jevs.2017.01.016'" tppabs="https://doi.org/10.1016%2Fj.jevs.2017.01.016" class="external text external">10.1016/j.jevs.2017.01.016</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0737-0806  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0737-0806'" tppabs="https://www.worldcat.org/issn/0737-0806" class="external text external">0737-0806</a>.</cite></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFWanamakerMassey2014" class="citation book cs1">Wanamaker, Boyce P.; Massey, Kathy (25 March 2014). <i>Applied Pharmacology for Veterinary Technicians - E-Book</i>. Elsevier Health Sciences. p.<span>&nbsp;</span>392. ISBN<span>&nbsp;</span><bdi>978-0-323-29170-5</bdi>.</cite></span></li><li id="cite_note-papich-40"> <span id="mw-reference-text-cite_note-papich-40" class="mw-reference-text"><cite id="CITEREFPapich2015" class="citation book cs1">Papich, Mark G. (October 2015). "Amikacin". <a href="javascript:if(confirm('https://books.google.com/books?id=ip8_CwAAQBAJ&pg=PA25  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ip8_CwAAQBAJ&pg=PA25'" tppabs="https://books.google.com/books?id=ip8_CwAAQBAJ&pg=PA25" class="external text external"><i>Saunders Handbook of Veterinary Drugs: Small and Large Animal</i></a> (4th ed.). Elsevier Health Sciences. pp.<span>&nbsp;</span>25–27. ISBN<span>&nbsp;</span><bdi>978-0-323-24485-5</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170910172330/https://books.google.com/books?id=ip8_CwAAQBAJ&pg=PA25  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170910172330/https://books.google.com/books?id=ip8_CwAAQBAJ&pg=PA25'" tppabs="https://web.archive.org/web/20170910172330/https://books.google.com/books?id=ip8_CwAAQBAJ&pg=PA25" class="external text external">Archived</a> from the original on 10 September 2017.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/amikacin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/amikacin'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/amikacin" class="external text external">"Amikacin"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antibiotics_and_chemotherapeutics_for_dermatological_use_(D06)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antibiotics_and_chemotherapeutics_for_dermatological_use_(D06)" style="font-size:114%;margin:0 4em">Antibiotics and chemotherapeutics for dermatological use (D06)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Antibiotics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a> and derivatives</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Demeclocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Demeclocycline" title="Demeclocycline">Demeclocycline</a></li>
<li>Chlortetracycline</li>
<li><a href="Oxytetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxytetracycline" title="Oxytetracycline">Oxytetracycline</a></li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphenicol" title="Amphenicol">Amphenicol</a>: <a href="Chloramphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloramphenicol" title="Chloramphenicol">Chloramphenicol</a></li></ul>

<ul><li>Aminoglycosides: <a href="Neomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Neomycin" title="Neomycin">Neomycin</a></li>
<li><a href="Gentamicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gentamicin" title="Gentamicin">Gentamicin</a></li>
<li><a href="Amikacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Amikacin" title="Amikacin">Amikacin</a></li></ul>

<ul><li>Quinolones: <a href="Nadifloxacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nadifloxacin" title="Nadifloxacin">Nadifloxacin</a></li></ul>

<ul><li>Streptogramin: Virginiamycin</li></ul>

<ul><li>Rifamycin: <a href="Rifaximin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifaximin" title="Rifaximin">Rifaximin</a></li></ul>

<ul><li><i>other:</i> <a href="Fusidic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fusidic_acid" title="Fusidic acid">Fusidic acid</a></li>
<li><a href="Bacitracin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bacitracin" title="Bacitracin">Bacitracin</a></li>
<li>Tyrothricin</li>
<li><a href="Mupirocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mupirocin" title="Mupirocin">Mupirocin</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Chemotherapeutics</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Sulfonamides</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Silver sulfadiazine</li>
<li><a href="Sulfathiazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfathiazole" title="Sulfathiazole">Sulfathiazole</a></li>
<li>Mafenide</li>
<li><a href="Sulfamethizole.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfamethizole" title="Sulfamethizole">Sulfamethizole</a></li>
<li><a href="Sulfanilamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfanilamide" title="Sulfanilamide">Sulfanilamide</a></li>
<li><a href="Sulfamerazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfamerazine" title="Sulfamerazine">Sulfamerazine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Antivirals</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Aciclovir" title="Aciclovir">Aciclovir</a></li>
<li><a href="Penciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Penciclovir" title="Penciclovir">Penciclovir</a></li>
<li><a href="Idoxuridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Idoxuridine" title="Idoxuridine">Idoxuridine</a></li>
<li><a href="Edoxudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Edoxudine" title="Edoxudine">Edoxudine</a></li>
<li><a href="Imiquimod.htm" tppabs="https://ptable.com/wiki/compounds/A/Imiquimod" title="Imiquimod">Imiquimod</a></li>
<li>Resiquimod</li>
<li><a href="Podophyllotoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Podophyllotoxin" title="Podophyllotoxin">Podophyllotoxin</a></li>
<li><a href="Docosanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Docosanol" title="Docosanol">Docosanol</a></li>
<li>Tromantadine</li>
<li><a href="Inosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Inosine" title="Inosine">Inosine</a></li>
<li>Lysozyme</li>
<li>Ibacitabine</li>
<li><a href="Lysine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysine" title="Lysine">Lysine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Ingenol mebutate</li>
<li><a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">Metronidazole</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Antibacterials_that_inhibit_protein_synthesis_(J01A,_J01B,_J01F,_J01G,_QJ01XQ)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antibacterials_that_inhibit_protein_synthesis_(J01A,_J01B,_J01F,_J01G,_QJ01XQ)" style="font-size:114%;margin:0 4em">Antibacterials that inhibit protein synthesis (J01A, J01B, J01F, J01G, QJ01XQ)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">30S</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Aminoglycosides<br>(initiation inhibitors)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">-mycin (<i>Streptomyces</i>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Streptomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Streptomycin" title="Streptomycin">Streptomycin</a><sup>#</sup></li>
<li>Dihydrostreptomycin</li></ul>

<ul><li><a href="Neomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Neomycin" title="Neomycin">Neomycin</a><sup>#</sup>
<ul><li><a href="Framycetin.htm" tppabs="https://ptable.com/wiki/compounds/A/Framycetin" title="Framycetin" class="mw-redirect">Framycetin</a></li>
<li>Paromomycin</li>
<li><a href="Ribostamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ribostamycin" title="Ribostamycin">Ribostamycin</a></li></ul></li></ul>

<ul><li><a href="Kanamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Kanamycin" title="Kanamycin" class="mw-redirect">Kanamycin</a>
<ul><li><a href="Amikacin.htm" tppabs="https://ptable.com/wiki/compounds/A/Amikacin" title="Amikacin">Amikacin</a><sup>#</sup></li>
<li>Arbekacin</li>
<li><a href="Bekanamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bekanamycin" title="Bekanamycin">Bekanamycin</a></li>
<li>Dibekacin</li>
<li><a href="Tobramycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tobramycin" title="Tobramycin">Tobramycin</a></li></ul></li></ul>

<ul><li><a href="Spectinomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Spectinomycin" title="Spectinomycin">Spectinomycin</a><sup>#</sup></li>
<li><a href="Hygromycin_B.htm" tppabs="https://ptable.com/wiki/compounds/A/Hygromycin_B" title="Hygromycin B">Hygromycin B</a></li>
<li><a href="Apramycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apramycin" title="Apramycin">Apramycin</a></li>
<li><a href="Puromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Puromycin" title="Puromycin">Puromycin</a></li>
<li>Nourseothricin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">-micin (<i>Micromonospora</i>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Gentamicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Gentamicin" title="Gentamicin">Gentamicin</a><sup>#</sup>
<ul><li><a href="Netilmicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Netilmicin" title="Netilmicin">Netilmicin</a></li>
<li>Sisomicin</li>
<li>Plazomicin<sup>†</sup></li>
<li>Isepamicin</li></ul></li></ul>

<ul><li>Verdamicin</li></ul>

<ul><li>Astromicin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tetracycline antibiotics<br>(tRNA binding)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Tetracyclines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Doxycycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxycycline" title="Doxycycline">Doxycycline</a><sup>#</sup></li>
<li>Chlortetracycline</li>
<li><a href="Clomocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomocycline" title="Clomocycline">Clomocycline</a></li>
<li><a href="Demeclocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Demeclocycline" title="Demeclocycline">Demeclocycline</a></li>
<li>Eravacycline</li>
<li><a href="Lymecycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Lymecycline" title="Lymecycline">Lymecycline</a></li>
<li>Meclocycline<sup>‡</sup></li>
<li><a href="Metacycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metacycline" title="Metacycline">Metacycline</a></li>
<li><a href="Minocycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Minocycline" title="Minocycline">Minocycline</a></li>
<li>Omadacycline</li>
<li><a href="Oxytetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxytetracycline" title="Oxytetracycline">Oxytetracycline</a></li>
<li>Penimepicycline</li>
<li><a href="Rolitetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Rolitetracycline" title="Rolitetracycline">Rolitetracycline</a></li>
<li>Sarecycline</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a><sup>#</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Glycylcyclines</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Tigecycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tigecycline" title="Tigecycline">Tigecycline</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">50S</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="2-Oxazolidone.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Oxazolidone" title="2-Oxazolidone">Oxazolidinone</a><br>(initiation inhibitors)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Eperezolid</li>
<li><a href="Linezolid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linezolid" title="Linezolid">Linezolid</a><sup>#</sup></li>
<li>Posizolid</li>
<li>Radezolid</li>
<li>Ranbezolid</li>
<li>Sutezolid</li>
<li>Tedizolid</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Peptidyl transferase</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Amphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Amphenicol" title="Amphenicol">Amphenicols</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Chloramphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloramphenicol" title="Chloramphenicol">Chloramphenicol</a><sup>#</sup></li>
<li>Azidamfenicol</li>
<li><a href="Thiamphenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiamphenicol" title="Thiamphenicol">Thiamphenicol</a></li>
<li><a href="Florfenicol.htm" tppabs="https://ptable.com/wiki/compounds/A/Florfenicol" title="Florfenicol">Florfenicol</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pleuromutilins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Lefamulin</li>
<li><a href="Retapamulin.htm" tppabs="https://ptable.com/wiki/compounds/A/Retapamulin" title="Retapamulin">Retapamulin</a></li>
<li>Tiamulin</li>
<li>Valnemulin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">MLS (transpeptidation/translocation)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Macrolides</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Azithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Azithromycin" title="Azithromycin">Azithromycin</a><sup>#</sup></li>
<li>Boromycin</li>
<li><a href="Clarithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clarithromycin" title="Clarithromycin">Clarithromycin</a><sup>#</sup></li>
<li><a href="Dirithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dirithromycin" title="Dirithromycin">Dirithromycin</a></li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a><sup>#</sup></li>
<li>Flurithromycin</li>
<li><a href="Josamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Josamycin" title="Josamycin">Josamycin</a></li>
<li>Midecamycin</li>
<li>Miocamycin</li>
<li><a href="Oleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oleandomycin" title="Oleandomycin">Oleandomycin</a></li>
<li>Rokitamycin</li>
<li><a href="Roxithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Roxithromycin" title="Roxithromycin">Roxithromycin</a></li>
<li>Spiramycin</li>
<li><a href="Troleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li>
<li><a href="Tylosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tylosin" title="Tylosin">Tylosin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ketolides</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Telithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Telithromycin" title="Telithromycin">Telithromycin</a><sup>‡</sup></li>
<li>Cethromycin</li>
<li>Solithromycin<sup>†</sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Lincosamides</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">Clindamycin</a><sup>#</sup></li>
<li><a href="Lincomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lincomycin" title="Lincomycin">Lincomycin</a></li>
<li>Pirlimycin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Streptogramins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Pristinamycin</li>
<li>Quinupristin/dalfopristin</li>
<li>Virginiamycin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">EF-G</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Steroid_antibacterials" scope="row" class="navbox-group" style="width:1%">Steroid antibacterials</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Fusidic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Fusidic_acid" title="Fusidic acid">Fusidic acid</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>








<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-03" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Amikacin&oldid=971010820  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Amikacin&oldid=971010820'" tppabs="https://en.wikipedia.org/wiki/?title=Amikacin&oldid=971010820">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>